Cargando…

Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan

The oral poliovirus vaccine (OPV) has been the mainstay of polio eradication, especially in low-income countries, and its use has eliminated wild poliovirus type 2. However, the inactivated poliovirus vaccine (IPV) is safer than OPV, as IPV protects against paralytic poliomyelitis without producing...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Muhammad Atif, Soofi, Sajid Bashir, Hussain, Imtiaz, Ahmed, Imran, Hussain, Zamir, Tahir, Rehman, Anwar, Saeed, Cousens, Simon, Bhutta, Zulfiqar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534550/
https://www.ncbi.nlm.nih.gov/pubmed/37766121
http://dx.doi.org/10.3390/vaccines11091444
_version_ 1785112420938678272
author Habib, Muhammad Atif
Soofi, Sajid Bashir
Hussain, Imtiaz
Ahmed, Imran
Hussain, Zamir
Tahir, Rehman
Anwar, Saeed
Cousens, Simon
Bhutta, Zulfiqar A.
author_facet Habib, Muhammad Atif
Soofi, Sajid Bashir
Hussain, Imtiaz
Ahmed, Imran
Hussain, Zamir
Tahir, Rehman
Anwar, Saeed
Cousens, Simon
Bhutta, Zulfiqar A.
author_sort Habib, Muhammad Atif
collection PubMed
description The oral poliovirus vaccine (OPV) has been the mainstay of polio eradication, especially in low-income countries, and its use has eliminated wild poliovirus type 2. However, the inactivated poliovirus vaccine (IPV) is safer than OPV, as IPV protects against paralytic poliomyelitis without producing adverse reactions. The present study compared mucosal and humoral responses to poliovirus vaccines administered to previously OPV-immunized children to assess the immunity gap in children in areas of high poliovirus transmission. A cluster-randomized trial was implemented in three high-risk districts of Pakistan—Karachi, Kashmore, and Bajaur—from June 2013 to May 2014. This trial was community-oriented and included three arms, focusing on healthy children below five years of age. The study involved the randomization of 387 clusters, of which 360 were included in the final analysis. The control arm (A) received the routine polio program bivalent poliovirus vaccine (bOPV). The second arm (B) received additional interventions, including health camps providing routine vaccinations and preventive maternal and child health services. In addition to the interventions in arm B, the third arm (C) was also provided with IPV. Blood and stool samples were gathered from children to evaluate humoral and intestinal immunity. The highest levels of poliovirus type 1 serum antibodies were observed in Group C (IPV + OPV). The titers for poliovirus type 2 (P2) and poliovirus type 3 (P3) were noticeably higher in those who had received a routine OPV dose than in those who had not across all study groups and visits. Providing an IPV booster after at least two OPV doses could potentially fill immunity gaps in regions where OPV does not show high efficacy. However, IPV only marginally enhances humoral immunity and fails to offer intestinal immunity, which is critical to stop the infection and spread of live poliovirus in populations that have not been exposed before.
format Online
Article
Text
id pubmed-10534550
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105345502023-09-29 Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan Habib, Muhammad Atif Soofi, Sajid Bashir Hussain, Imtiaz Ahmed, Imran Hussain, Zamir Tahir, Rehman Anwar, Saeed Cousens, Simon Bhutta, Zulfiqar A. Vaccines (Basel) Article The oral poliovirus vaccine (OPV) has been the mainstay of polio eradication, especially in low-income countries, and its use has eliminated wild poliovirus type 2. However, the inactivated poliovirus vaccine (IPV) is safer than OPV, as IPV protects against paralytic poliomyelitis without producing adverse reactions. The present study compared mucosal and humoral responses to poliovirus vaccines administered to previously OPV-immunized children to assess the immunity gap in children in areas of high poliovirus transmission. A cluster-randomized trial was implemented in three high-risk districts of Pakistan—Karachi, Kashmore, and Bajaur—from June 2013 to May 2014. This trial was community-oriented and included three arms, focusing on healthy children below five years of age. The study involved the randomization of 387 clusters, of which 360 were included in the final analysis. The control arm (A) received the routine polio program bivalent poliovirus vaccine (bOPV). The second arm (B) received additional interventions, including health camps providing routine vaccinations and preventive maternal and child health services. In addition to the interventions in arm B, the third arm (C) was also provided with IPV. Blood and stool samples were gathered from children to evaluate humoral and intestinal immunity. The highest levels of poliovirus type 1 serum antibodies were observed in Group C (IPV + OPV). The titers for poliovirus type 2 (P2) and poliovirus type 3 (P3) were noticeably higher in those who had received a routine OPV dose than in those who had not across all study groups and visits. Providing an IPV booster after at least two OPV doses could potentially fill immunity gaps in regions where OPV does not show high efficacy. However, IPV only marginally enhances humoral immunity and fails to offer intestinal immunity, which is critical to stop the infection and spread of live poliovirus in populations that have not been exposed before. MDPI 2023-09-01 /pmc/articles/PMC10534550/ /pubmed/37766121 http://dx.doi.org/10.3390/vaccines11091444 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Habib, Muhammad Atif
Soofi, Sajid Bashir
Hussain, Imtiaz
Ahmed, Imran
Hussain, Zamir
Tahir, Rehman
Anwar, Saeed
Cousens, Simon
Bhutta, Zulfiqar A.
Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title_full Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title_fullStr Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title_full_unstemmed Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title_short Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
title_sort does ipv boost intestinal immunity among children under five years of age? an experience from pakistan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534550/
https://www.ncbi.nlm.nih.gov/pubmed/37766121
http://dx.doi.org/10.3390/vaccines11091444
work_keys_str_mv AT habibmuhammadatif doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT soofisajidbashir doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT hussainimtiaz doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT ahmedimran doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT hussainzamir doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT tahirrehman doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT anwarsaeed doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT cousenssimon doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan
AT bhuttazulfiqara doesipvboostintestinalimmunityamongchildrenunderfiveyearsofageanexperiencefrompakistan